Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals

Veterinary Immunology and Immunopathology

Volumn 105, Issue 1-2, 2005, Pages 47-57

  Foote, C E ^a   Love, D N ^b   Gilkerson, J R ^c   Rota, J ^d   Trevor Jones, P ^d   Ruitenberg, K M ^a   Wellington, J E ^a   Whalley, J M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Antibody response; Equine herpesvirus 1 (EHV 1); Glycoprotein D (gD)

Indexed keywords

CD79B ANTIGEN; DNA; DUVAXYN; GLYCOPROTEIN D; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; ISCOMATRIX; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN; VIRUS VACCINE; DNA VACCINE; GLYCOPROTEIN D, EQUID HERPESVIRUS 1; IMMUNOLOGICAL ADJUVANT; SUBUNIT VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GLYCOSYLATION; HERPES SIMPLEX VIRUS 1; HORSE; INOCULATION; MOLECULAR WEIGHT; NONHUMAN; PREGNANCY; VIRUS RECOMBINANT; WESTERN BLOTTING; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; EQUINE HERPES VIRUS; FEMALE; HERPES VIRUS INFECTION; HORSE DISEASE; IMMUNIZATION; IMMUNOLOGY; NEWBORN; SERODIAGNOSIS; VIROLOGY;

ANIMALIA; EQUIDAE; EQUINE HERPESVIRUS 1; EQUUS CABALLUS; HUMAN HERPESVIRUS 1; MAMMALIA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; IMMUNIZATION; NEUTRALIZATION TESTS; PREGNANCY; RECOMBINANT PROTEINS; VACCINES, DNA; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 18744369612     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2004.12.012     Document Type: Article

References (40)

1. Allen, G.P., Bryans, J.T., 1986. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. In: Pandey, R. (Ed.), Progress in Veterinary Microbiology and Immunology, pp. 78-144.
2. Allen, G.P., Kydd, J.H., Slater, J.D., Smith, K.C., 1999. Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion. In: Wernery, J.W.U., Mumford, J., Kaaden, O.R. (Eds.), Proceedings of the Eighth International Conference of Equine Infectious Diseases. R&W Publication, Dubai, pp. 129-146.
3. Allen, G.P., 2002. Respiratory infections by equine herpesvirus types 1 and 4. In: Lekeux, P (Ed.), Equine Respiratory Diseases. International Veterinary Information Service, New York, USA http://www.ivis.org/special-books/ Lekeux/allen.
4. Audonnet, J.C., Mumford, J.A., Jessett, D., Pardo, M.C., Taylor, J., Tartaglia, J., Minke, J.M., 1999. Safety and efficacy of a canarypox-EHV- recombinant vaccine in horses. In: Wernery, J.W.U., Mumford, J., Kaaden, O.R. (Eds.), Proceedings of the Eighth International Conference of Equine Infectious Diseases. R&W Publication, Dubai, pp. 418-419.
5. Breathnach, C.C., Yeargan, M.R., Sheoran, A.S., Allen, G.P., 2001. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Equine Vet. J. 33, 651-657.
6. Cox, J., Coulter, A., Macfarlan, R., Beezum, L., Bates, J., Wong, T., Drane, D., 1997. Development of an influenza-ISCOM™ vaccine. In: Gregoriadis, G., McCormack, B., Allison, A.C. (Eds.), Vaccine Design: The Role of Cytokine Networks, Plenum Press, New York, pp. 33-49.
7. Crabb, B.S., Macpherson, C.M., Reubel, G.H., Browning, G.F., Studdert, M.J., Drummer, H.E., 1995. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch. Virol. 140, 245-258.
8. Crabb, B.S., Studdert, M.J., 1995. Equine herpesvirus 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv. Virus Res. 45, 153-190.
9. Cullinane, A.A., Neilan, J., Wilson, L., Davison, A.J., Allen, G., 1993. The DNA sequence of the equine herpesvirus 4 gene encoding glycoprotein gp 17/18, the homologue of herpes simplex virus glycoprotein gD. J. Gen. Virol. 74, 1959-1964.
10. Dean, A.G., Dean, J.A., Coulombier, D., Brendel, K.A., Smith, D.C., Burton, A.H., Dicker, R.C., Sullivan, K., Pagan, R.F., Arner, T.G., 1994. Epi Info, Version 6: a word processing, database and statistics for epidemiology on microcomputers.
11. Flowers, C.C., O'Callaghan, D.J., 1992. Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope. J. Virol. 66, 6451-6460.
12. Foote, C.E., Love, D.N., Gilkerson, J.R., Whalley, J.M., 2004. Detection of EHV-1 and EHV-4 DNA in unweaned Thoroughbred foals from vaccinated mares on a large stud farm. Equine Vet. J. 36, 341-345.
13. Gilkerson, J.R., Love, D.N., Whalley, J.M., 1997. Serological evidence of equine herpesvirus 1 (EHV-1) infection in Thoroughbred foals 30-120 days of age. Aust. Eq. Vet. 15, 128-134.
14. Harlow, E., Lane, D., 1988. Antibodies - A Laboratory Manual. Cold Spring Harbour Laboratory Press, New York, pp. 90-91.
15. Kukreja, A., Love, D.N., Whalley, J.M., Field, H.J., 1998. Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model. Vet. Microbiol. 60, 1-11.
16. Lipford, G.B., Wagner, H., Heeg, K., 1994. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 12, 73-80.
17. Little-van den Hurk, S.V., Tikoo, S.K., van den Hurk, J.V., Babiuk, L.A., van Donkersgoed, J., 1997. Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV-1) vaccines. Vaccine 15, 36-44.
18. Love, D.N., Bell, C.W., Whalley, J.M., 1992. Characterization of the glycoprotein D gene products of equine herpesvirus 1 using a prokaryotic cell expression vector. Vet. Microbiol. 30, 387-394.
19. Love, D.N., Bell, C.W., Pye, D., Edwards, S., Hayden, M., Lawrence, G.L., Boyle, D., Pye, T., Whalley, J.M., 1993. Expression of equine herpesvirus-1 glycoprotein-D by using a recombinant baculovirus. J. Virol. 67, 6820-6823.
20. Mizukoshi, F., Maeda, K., Hamano, M., Iwata, H., Matsumura, T., Kondo, T., Sugiura, T., 2002. IgG antibody subclass response against equine herpesvirus type 4 in horses. Vet. Immunol. Immunop. 88, 97-101.
21. Nelson, K.M., Schram, B.R., McGregor, M.W., Sheoran, A.S., Olsen, C.W., Lunn, D.P., 1998. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 16, 1306-1313.
22. Nordengrahn, A., Merza, M., Svedlund, G., Roneus, M., Treiberg-Berndtson, L., Lindholm, A., Drummer, H.E., Studdert, M.J., Absugra, I., Gunnarsson, E., Klingeborn, B., 1999. A field study of the application of a type-specific test distinguishing antibodies to equine herpesvirus-1 and -4. In: Wernery, J.W.U., Mumford, J., Kaaden, O.R. (Eds.), Proceedings of the Eighth International Conference of Equine Infectious Diseases. R&W Publication, Dubai, pp. 125-128.
23. Osterrieder, N., Wagner, R., Brandmuller, C., Schmidt, P., Wolf, H., Kaaden, O.R., 1995. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208, 500-510.
24. Packiarajah, P., Walker, C., Gilkerson, J.R., Whalley, J.M., Love, D.N., 1998. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in Balb/C mice. Vet. Microbiol. 61, 261-278.
25. Patel, J.R., Bateman, H., Williams, J., Didlick, S., 2003a. Derivation and characterisation of a live equid herpesvirus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1. Vet. Microbiol. 91, 23-39.
26. Patel, J.R., Foldi, J., Bateman, H., Williams, J., Didlick, S., Stark, R., 2003b. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Vet. Microbiol. 92, 1-17.
27. Reed, J., Muench, H., 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493.
28. Ruitenberg, K.M., Gilkerson, J.R., Wellington, J.E., Love, D.N., Whalley, J.M., 2001. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease. Virus Res. 79, 125-135.
29. Ruitenberg, K.M., Walker, C., Wellington, J.E., Love, D.N., Whalley, J.M., 1999. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection. Vaccine 17, 237-244.
30. Ruitenberg, K.M., Love, D.N., Gilkerson, J.A., Wellington, J.E., Whalley, J.M., 2000a. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody. Vet. Microbiol. 76, 117-127.
31. Ruitenberg, K.M., Walker, C., Love, D.N., Wellington, J.E., Whalley, J.M., 2000b. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine 18, 1367-1373.
32. Sheoran, A.S., Lunn, D.P., Holmes, M.A., 1998. Monoclonal antibodies to subclass-specific antigenic determinants on equine immunoglobulin gamma chains and their characterization. Vet. Immunol. Immunop. 62, 153-165.
33. Stokes, A., Cameron, R.S., Marshall, R.N., Killington, R.A., 1997. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2K(k)) murine model. Virus Res. 50, 159-173.
34. Sugiura, T., Kondo, T., Matsumara, T., Kamada, M., 1994. IgG subclass responses in equid herpesvirus-1 infected horses. In: Nakajima, H., Plowright, W. (Eds.), Proceedings of the Seventh International Conference on Equine Infectious Diseases. R&W Publication, Newmarket, p. 350.
35. Sugiura, T., Kondo, T., Imagawa, H., 1999. Immunoglobulin isotype responses in getah virus, equine infectious anaemia and herpesvirus-1 infections. In: Wernery, J.W.U., Mumford, J., Kaaden, O.R. (Eds.), Proceedings of the Eighth International Conference of Equine Infectious Diseases. R&W Publication, Dubai, p. 220.
36. Tewari, D., Whalley, J.M., Love, D.N., Field, H.J., 1994. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75, 1735-1741.
37. van Maanen, C., Bruin, G., de Boer-Luijtze, Smolders, G., de Boer, G.F., 1992. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. Vet. Quart. 14, 13-17.
38. Wellington, J.E., Lawrence, G.L., Love, D.N., Whalley, J.M., 1996. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch. Virol. 141, 1785-1793.
39. Wilson, W.D., Mihaly, J.E., Hussey, S., Lunn, D.P., 2001. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Eq. Vet. J. 33, 644-650.
40. Zhang, Z., Smith, P.M., Target, E.B., Osterrieder, N., Jennings, R., O'Callaghan, D.J., 1998. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD. Virus Res. 56, 11-24.